Krane Funds Advisors LLC Sells 12,747 Shares of Infosys Limited (NYSE:INFY)

Krane Funds Advisors LLC reduced its stake in shares of Infosys Limited (NYSE:INFY) by 16.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 64,672 shares of the technology company’s stock after selling 12,747 shares during the quarter. Infosys accounts for 0.1% of Krane Funds Advisors LLC’s holdings, making the stock its 29th biggest holding. Krane Funds Advisors LLC’s holdings in Infosys were worth $1,418,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. FMR LLC grew its holdings in Infosys by 77.8% during the 3rd quarter. FMR LLC now owns 170,704 shares of the technology company’s stock worth $3,802,000 after acquiring an additional 74,697 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Infosys by 62.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 514,838 shares of the technology company’s stock valued at $11,465,000 after buying an additional 198,192 shares during the period. Captrust Financial Advisors raised its position in shares of Infosys by 32.5% during the third quarter. Captrust Financial Advisors now owns 21,718 shares of the technology company’s stock worth $484,000 after purchasing an additional 5,325 shares during the period. Benjamin Edwards Inc. acquired a new position in shares of Infosys during the third quarter valued at about $232,000. Finally, Quantinno Capital Management LP boosted its stake in Infosys by 47.4% during the 3rd quarter. Quantinno Capital Management LP now owns 86,985 shares of the technology company’s stock valued at $1,937,000 after purchasing an additional 27,972 shares during the last quarter. 16.20% of the stock is currently owned by institutional investors and hedge funds.

Infosys Trading Down 4.5 %

Shares of Infosys stock opened at $16.58 on Monday. The firm has a market cap of $68.66 billion, a PE ratio of 20.98, a PEG ratio of 3.50 and a beta of 0.97. The stock has a 50 day moving average of $20.08 and a 200 day moving average of $21.56. Infosys Limited has a 12 month low of $16.04 and a 12 month high of $23.63.

Infosys (NYSE:INFY) last announced its quarterly earnings data on Thursday, January 16th. The technology company reported $0.19 EPS for the quarter, meeting the consensus estimate of $0.19. Infosys had a return on equity of 31.60% and a net margin of 17.28%. During the same period in the prior year, the firm posted $0.18 EPS. As a group, equities research analysts forecast that Infosys Limited will post 0.74 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have weighed in on INFY. Hsbc Global Res upgraded shares of Infosys from a “hold” rating to a “strong-buy” rating in a research note on Monday, December 9th. CLSA upgraded shares of Infosys from a “hold” rating to an “outperform” rating in a research report on Friday, March 7th. HSBC raised Infosys from a “hold” rating to a “buy” rating in a research note on Monday, December 9th. StockNews.com lowered shares of Infosys from a “buy” rating to a “hold” rating in a research report on Thursday, March 20th. Finally, Guggenheim reissued a “neutral” rating on shares of Infosys in a report on Friday, January 17th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Infosys currently has an average rating of “Hold” and an average target price of $19.70.

Infosys Company Profile

Infosys Ltd. is a digital services and consulting company, which engages in the provision of end-to-end business solutions. It operates through the following segments: Financial Services, Retail, Communication, Energy, Utilities, Resources, and Services, Manufacturing, Hi-Tech, Life Sciences, and All Other.